Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group

Neurology
N StamblerJ M Cedarbaum

Abstract

We analyzed data from the 245-patient placebo group of the ALS CNTF Treatment Study Group study, a large, prospective, multicenter study of recombinant human ciliary neurotrophic factor to determine prognostic factors for length of survival in ALS. Variables examined included baseline demographic characteristics, indices of disease severity, pulmonary function, and clinical laboratory tests. Shorter survival was associated with greater age, lower percent-predicted forced vital capacity (FVC%), and lower serum chloride at study entry. A shorter interval from symptom onset to diagnosis of ALS and greater weight loss in the 2 months before study entry also predicted shortened survival times. The rate of muscle strength loss before study entry did not predict risk of mortality. Serum chloride, reflecting the degree of respiratory acidosis, was identified for the first time as being correlated with prognosis in ALS. The relationship between a patient's FVC% and the probability of survival is described.

References

Jan 1, 1996·Neuroepidemiology·S WarrenK G Warren
Jan 7, 1998·Journal of the Neurological Sciences·J M Cedarbaum, N Stambler

❮ Previous
Next ❯

Citations

Jun 15, 2006·Journal of Neurology·Adam CzaplinskiStanley H Appel
Feb 19, 2009·Journal of Neurology·Julie Phukan, Orla Hardiman
Nov 18, 2010·Journal of Neurology·Orla Hardiman
Dec 16, 1998·Journal of the Neurological Sciences·M Swash
Jun 29, 1999·Journal of the Neurological Sciences·K A KleopaT Heiman-Patterson
Dec 14, 1999·Journal of the Neurological Sciences·E J KasarskisJ M Cedarbaum
Nov 1, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J GilP Couratier
Nov 2, 2004·American Journal of Respiratory and Critical Care Medicine·Ross K MorganRichard W Costello
Jun 27, 2003·American Journal of Respiratory and Critical Care Medicine·Franco Laghi, Martin J Tobin
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Merit CudkowiczJeremy Shefner
Aug 13, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Ryoichi NakamuraGen Sobue
Jan 25, 2003·Acta Neurologica Scandinavica·M B ChaudriD Jefferson
May 23, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·M D BradleyR S Howard
Jan 2, 2003·Postgraduate Medical Journal·R S Howard, R W Orrell
Dec 3, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·P N LeighUNKNOWN King's MND Care and Research Team
Feb 18, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·A CzaplinskiS H Appel
Jul 13, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·S KalraD L Arnold
Nov 8, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·Christen L ShoesmithMichael J Strong
Jan 12, 2013·Cell Death and Differentiation·A T BehanJ H M Prehn
Jan 24, 2013·Stem Cells Translational Medicine·Maria Teresa González-GarzaJorge E Moreno-Cuevas
Aug 16, 2006·Neuro-degenerative Diseases·Vincent Meininger
Aug 7, 2010·Advances in Experimental Medicine and Biology·J Jefferson P PerryJohn A Tainer
May 19, 2006·Expert Review of Molecular Diagnostics·Robert BowserRima Kaddurah-Daouk
Feb 13, 2016·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Malcolm ProudfootMartin R Turner
Jun 8, 2012·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·William J ScottonAmmar Al-Chalabi
Dec 1, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·J A Liberty JenkinsRobert G Miller
Dec 17, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Guillaume GautierJean Pouget
Jul 27, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Juan GilPhilippe Couratier
Oct 25, 2002·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Jeffrey Rosenfeld
Oct 25, 2002·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Carlayne E Jackson
Nov 16, 2010·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Maya Abdelnour-MalletPierre-François Pradat
Jul 9, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Muddasir QureshiMerit E Cudkowicz
Jun 19, 2004·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·S C Bourke, G J Gibson
Nov 26, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Jesus SanchoJesus Gonzalez-Bermejo
May 20, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Fusun BaumannPamela A McCombe
Mar 21, 2006·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Catherine HeffernanMary-Ann Ampong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.